A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia

Cancer Genetics and Cytogenetics

Volumn 175, Issue 1, 2007, Pages 52-56

  Bacher, Ulrike ^a   Haferlach, Torsten ^b   Kern, Wolfgang ^b   Harich, Hans Detlev ^c   Schnittger, Susanne ^b   Haferlach, Claudia ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^c Oncological Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD LEVEL; BONE MARROW CELL; CASE REPORT; CHROMOSOME 17Q; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHRONIC DISEASE; CLONE; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETIC VARIABILITY; GRANULOPOIESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KARYOTYPE; KARYOTYPE 46,XY; MALE; MALIGNANT TRANSFORMATION; MEGAKARYOPOIESIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; TREATMENT DURATION;

CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME PAINTING; DISEASE PROGRESSION; HUMANS; HYDROXYUREA; KARYOTYPING; LEUKEMIA, T-CELL, ACUTE; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; NUCLEIC ACID SYNTHESIS INHIBITORS; SYNDROME;

EID: 34247847812     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.12.007     Document Type: Article

References (28)

1. Disperati P., Ichim C.V., Tkachuk D., Chun K., Schuh A.C., and Wells R.A. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res 30 (2006) 233-239
2. Suzuki M., Abe A., Kiyoi H., Murata M., Ito Y., Shimada K., Morishita Y., Kinoshita T., and Naoe T. Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation. Leukemia 20 (2006) 1168-1169
3. Bierings M., Szczepanski T., van Wering E.R., Willemse M.J., Langerak A.W., Revesz T., and van Dongen J.J. Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia. Br J Haematol 113 (2001) 757-762
4. Stass S., Mirro J., Melvin S., Pui C.H., Murphy S.B., and Williams D. Lineage switch in acute leukemia. Blood 64 (1984) 701-706
5. van Wering E.R., Beishuizen A., Roeffen E.T., van der Linden-Schrever B.E., Verhoeven M.A., Hahlen K., Hooijkaas H., and van Dongen J.J. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia 9 (1995) 1523-1533
6. Krawczuk-Rybak M., Zak J., and Jaworowska B. A lineage switch from AML to ALL with persistent translocation t(4;11) in congenital leukemia. Med Pediatr Oncol 41 (2003) 95-96
7. Saso R., Zomas A., Hamblin M., Dunlop L., Swansbury G.J., Min T., Singhal S., Powles R., Treleaven J., and Mehta J. Sequential development of myelodysplasia and acute myeloid leukemia but with no karyotypic evolution after autografting in a patient with Philadelphia positive acute lymphoblastic leukemia. Leuk Lymphoma 26 (1997) 625-628
8. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours (2001), IARC Press, Lyon
9. Yoshida C., Suzukawa K., Katsura Y., Shimizu S., Mukai H.Y., Hasegawa Y., Imagawa S., Kojima H., and Nagasawa T. T-cell acute lymphoblastic leukemia with add(1)(p36) and del(12)(p11) following acute myelocytic leukemia with partial deletion of 9p. Cancer Genet Cytogenet 150 (2004) 62-65
10. Kim J.P.C.J., Seo E.J., Lee J.H., Yoo S.J., Choi S.J., and Chi H.S. A case of biphenotypic blast crisis of unclassified myeloproliferative disorder. Ann Hematol 81 (2002) 603-604
11. JabbarAL-Obaidi MR N., White P., Pomfret M., Smith H., Starczynski J., and Johnson R. A fourth case of 8p11 myeloproliferative disorder transforming to B-lineage acute lymphoblastic leukaemia: a case report. Acta Haematol 107 (2002) 98-100
12. Bloomfield C.D., Shuma C., Regal L., Philip P.P., Hossfeld D.K., Hagemeijer A.M., Garson O.M., Peterson B.A., Sakurai M., Alimena G., Berger R., Rowley J.D., Ruutu T., Mitelman F., Dewald G.W., and Swansbury J. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 80 11 Suppl (1997) 2191-2198
13. Faderl S., Kantarjian H.M., Talpaz M., and Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91 (1998) 3995-4019
14. Secker-Walker L.M., Prentice H.G., Durrant J., Richards S., Hall E., and Harrison G. MRC Adult Leukaemia Working Party. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol 96 (1997) 601-610
15. Wetzler M., Dodge R.K., Mrozek K., Carroll A.J., Tantravahi R., Block A.W., Pettenati M.J., Le Beau M.M., Frankel S.R., Stewart C.C., Szatrowski T.P., Schiffer C.A., Larson R.A., and Bloomfield C.D. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood 93 (1999) 3983-3993
16. Heerema N.A., Sather H.N., Sensel M.G., Kraft P., Nachman J.B., Steinherz P.G., Lange B.J., Hutchinson R.S., Reaman G.H., Trigg M.E., Arthur D.C., Gaynon P.S., and Uckun F.M. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Clin Oncol 16 (1998) 1270-1278
17. Schneider N.R., Carroll A.J., Shuster J.J., Pullen D.J., Link M.P., Borowitz M.J., Camitta B.M., Katz J.A., and Amylon M.D. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood 96 (2000) 2543-2549
18. Iyer R.V., Sait S.N., Matsui S., Block A.W., Barcos M., Slack J.L., Wetzler M., and Baer M.R. Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome. Cancer Genet Cytogenet 148 (2004) 29-34
19. Schoch C., Kern W., Kohlmann A., Hiddemann W., Schnittger S., and Haferlach T. Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer 43 (2005) 227-385
20. Barbouti A., Stankiewicz P., Nusbaum C., Cuomo C., Cook A., Hoglund M., Johansson B., Hagemeijer A., Park S.S., Mitelman F., Lupski J.R., and Fioretos T. The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats. Am J Hum Genet 4 (2004) 1-10
21. Becher R., Carbonell F., and Bartram C.R. Isochromosome 17q in Ph1-negative leukemia: a clinical, cytogenetic, and molecular study. Blood 75 (1990) 1679-1683
22. Fioretos T., Strombeck B., Sandberg T., Johansson B., Billstrom R., Borg A., Nilsson P.G., Van Den Berghe H., Hagemeijer A., Mitelman F., and Hoglund M. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood 94 (1999) 225-232
23. Andersen M.K., Christiansen D.H., Jensen B.A., Ernst P., Hauge G., and Pedersen-Bjergaard J. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 114 (2001) 539-543
24. Felix C.A., Hosler M.R., Winick N.J., Masterson M., Wilson A.E., and Lange B.J. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 85 (1995) 3250-3256
25. Kaplinsky C., Frisch A., Cohen I.J., Goshen Y., Jaber L., Yaniv I., Stark B., Tamary H., and Zaizov R. T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma. Med Pediatr Oncol 20 (1992) 229-231
26. Pedersen-Bjergaard J. Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II. Leuk Res 16 (1992) 733-735
27. Abruzzese E., Buss D., Rainer R., Pettenati M.J., and Rao P.N. Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study. Ann Hematol 73 (1996) 35-38
28. Sato N., Nakazato T., Kizaki M., Ikeda Y., and Okamoto S. Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature. Int J Hematol 79 (2004) 147-151